EIN 84-5185853

Pancreatic Cancer North America

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2020
Most recent tax filings
2024-12-01
Description
Pancone Network's mission is to raise funds for research into the causes and prevention of pancreatic cancer, with a focus on disrupting traditional approaches by bringing together various sectors, innovations, and novel methods. They provided a research grant of $50,000 to Stand Up to Cancer (SU2C) for the PASS-01 clinical trial and two grants totaling $30,632 to Pancreatic Cancer Canada for precision medicine and early detection research at approved institutes.
Also known as...
Pancone Network
Total revenues
$128,661
2024
Total expenses
$167,270
2024
Total assets
$69,323
2024
Num. employees
0
2024

Program areas at Pancreatic Cancer North America

Pancreatic Cancer North America provided a research grant totaling $60,000 to the Dana-Farber Cancer Institute in support of the pilot study of psilocybin assisted therapy for opioid refractory cancer pain in patients with advanced cancer, and to advance the search for cures and prevention for all cancers.
Pancreatic Cancer North America continued its commitment to raising awareness of pancreatic cancer and advocating for greater supports, by working with healthcare professionals, allied organizations and in particular during World Pancreatic Cancer Day.
Pancreatic Cancer North America provided a grant totaling $19,375 to Cancer Care in support of the mental health and supportive counseling for people affected by cancer.

Grants made by Pancreatic Cancer North America

GranteeGrant descriptionAmount
Dana-Farber Cancer InstituteResearch$60,000
CancerCareProgram Support$19,375

Who funds Pancreatic Cancer North America

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
American Online Giving FoundationGeneral Support$26,410

Financials for Pancreatic Cancer North America

RevenuesFYE 12/2024
Total grants, contributions, etc.$128,661
Program services$0
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$128,661
Data update history
July 14, 2025
Posted financials
Added Form 990 for fiscal year 2024
July 13, 2025
Updated personnel
Identified 4 new personnel
March 26, 2025
Received grants
Identified 1 new grant, including a grant for $26,410 from American Online Giving Foundation
July 18, 2024
Posted financials
Added Form 990 for fiscal year 2023
November 25, 2023
Posted financials
Added Form 990 for fiscal year 2021
Nonprofit Types
Grantmaking organizationsDisease research fundraisersPublic health orgsHealth organizationsCharities
Issues
HealthDiseases and disordersCancer
Characteristics
Provides grantsConducts researchOperates internationallyNational levelTax deductible donationsNo full-time employeesAccepts online donations
General information
Address
442 5th Ave - Suite 2873
New York, NY 10018
Metro area
New York-Newark-Jersey City, NY-NJ-PA
County
New York County, NY
Website URL
pancreaticcancerna.org/ 
Phone
(844) 274-3640
IRS details
EIN
84-5185853
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2020
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
E60: Health Support Services
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
CT0273940
FTB Entity ID
4687818
AB 488 data last updated ("as-of") date
2025-08-20
Free account sign-up

Want updates when Pancreatic Cancer North America has new information, or want to find more organizations like Pancreatic Cancer North America?

Create free Cause IQ account